Previous 10 | Next 10 |
3 Things Penny Stocks Traders Need to Know in 2022 If you’re looking to trade penny stocks in 2022, it can be challenging. But, with the right information by your side, trading penny stocks right now can be much easier than previously imagined. Now, there are a few ways to ha...
Despite the ongoing global public health crisis, fundamentally-sound companies focused on diabetic treatments are seemingly unfazed. So, given Senseonics' (SENS) relative overvaluation and bleak growth prospects, we think it could be wise to bet on diabetes stocks Novo Nordisk (NVO), Eli Lill...
Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it plans to release its fourth quarter and ...
The shares of medical technology stock Senseonics Holdings (SENS) dipped marginally in price yesterday, despite the company receiving FDA approval for its Eversense E3 glucose monitoring system. So, with unsustainable valuations and a bleak earnings outlook, will SENS'stock be able to regain ...
ASCENSIA DIABETES CARE ANNOUNCES FDA APPROVAL OF THE EVERSENSE E3 CONTINUOUS GLUCOSE MONITORING SYSTEM FOR USE FOR UP TO 6 MONTHS PR Newswire PARSIPPANY, N.J. , Feb. 14, 2022 /PRNewswire/ -- Ascensia Diabetes Care, a global diabetes care company, announces that i...
Are These 3 Penny Stocks on Your Watchlist Right Now? So far, February has been a kinder month to those trading penny stocks then January. While 2022 as a whole has been wickedly volatile, we have also begun to see small glimpses of continued bullish sentiment. In the past few month...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...
Gainers: Kaival Brands Innovations KAVL +42%. Y-mAbs Therapeutics YMAB +29%. China Online Education (NYSE:COE) +24%. Mr. Cooper COOP +20%. Zillow Z +19%. Carpenter Technology (NYSE:CRS) +19% Zillow ZG +18%. Eqonex EQOS +17%. Bloom Energy BE +17%. XPEL (...
Gainers: Orphazyme ORPH +22%. Y-mAbs Therapeutics YMAB +11%. Oscar Health (NYSE:OSCR) +9%. Theravance Biopharma TBPH +9%. VistaGen Therapeutics (NASDAQ:VTGN) +8%. Losers: ProQR Therapeutics PRQR -72%. Senseonics SENS -19%. PetVivo P...
Senseonics Holdings (NYSE:SENS) announced on Friday the FDA approval of its next-gen Eversense E3 Continuous Glucose Monitoring System. The company anticipates the U.S. launch of the product to begin during Q2 2022 with the participation of its global commercial partner, Ascensia Diabetes Car...
News, Short Squeeze, Breakout and More Instantly...
Senseonics Holdings Inc. Company Name:
SENS Stock Symbol:
NYSE Market:
Senseonics Holdings Inc. Website:
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it plans to release its second quarter 2024 financial res...
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced business updates and provided its full year 2024 financial out...
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to host a business update and analyst event during the A...